Cargando…
Topical application of L-arginine blocks advanced glycation by ascorbic acid in the lens of hSVCT2 transgenic mice
PURPOSE: Previous experiments from our laboratory showed that the oral intake of selected guanidino compounds could block the formation of crystallin-bound advanced ascorbylation products. Here we tested whether these were also active when applied as eye drops. METHODS: Two month old hSVCT2 transgen...
Autores principales: | Fan, Xingjun, Xiaoqin, Liu, Potts, Breshey, Strauch, Christopher M., Nemet, Ina, Monnier, Vincent M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164690/ https://www.ncbi.nlm.nih.gov/pubmed/21897744 |
Ejemplares similares
-
The ascorbate transporter SVCT2 to target microglia-dependent inflammation
por: Portugal, Camila C., et al.
Publicado: (2017) -
Ascorbic acid analogue 6-Deoxy-6-[(18)F] fluoro-L-ascorbic acid as a tracer for identifying human colorectal cancer with SVCT2 overexpression
por: He, Peng, et al.
Publicado: (2021) -
Role of vitamin C and SVCT2 in neurogenesis
por: Salazar, Katterine, et al.
Publicado: (2023) -
Hormetic dose response to (L)-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression
por: Cho, Sungrae, et al.
Publicado: (2018) -
SVCT2-GLUT1-mediated ascorbic acid transport pathway in rat dental pulp and its effects during wound healing
por: Ohkura, Naoto, et al.
Publicado: (2023)